Fig. 3.

Forest plot of subgroup analysis comparing major and CRNM bleeding according to antithrombotic strategy (DAT or TAT). CRNM clinically relevant non-major, DAT dual antithrombotic therapy, TAT triple antithrombotic therapy, M-H Mantel–Haenszel, CI confidence interval, df degrees of freedom, inhib inhibitors